AMANDA BRATTON ANP
Prescription History 1093127607
Nurse Practitioner in Shelbyville, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AMANDA BRATTON ANP, an active Nurse Practitioner specialist practicing in Shelbyville, IN. Our medical registry currently tracks 43 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,941 documented patient claims. Among these therapy options, the most frequently utilized medication is Mounjaro, which accounts for 296 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| MounjaroTirzepatide | 296 | $1,648.88 | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 296 Medicare prescriptions for Mounjaro, about 5.4 times the volume of the typical Indiana prescriber of this medication (54.9). Medicare paid an average of $1,648.88 per fill, versus $1,279.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 453.5 30-Day Fills standardized to 30-day supplies 13,212 Days of Medication total across all patients in 2024 | |||
| OzempicSemaglutide | 175 | $1,649.11 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 175 Medicare prescriptions for Ozempic, about 2.8 times the volume of the typical Indiana prescriber of this medication (63). Medicare paid an average of $1,649.11 per fill, versus $1,314.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 298.7 30-Day Fills standardized to 30-day supplies 8,788 Days of Medication total across all patients in 2024 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 115 | $215.95 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 115 Medicare prescriptions for Lantus Solostar, about 2.5 times the volume of the typical Indiana prescriber of this medication (45.6). Medicare paid an average of $215.95 per fill, versus $141.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 303 30-Day Fills standardized to 30-day supplies 9,063 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl ErMetformin Hcl | 113 | $10.12 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 113 Medicare prescriptions for Metformin Hcl Er, about 1.8 times the volume of the typical Indiana prescriber of this medication (63.8). Medicare paid an average of $10.12 per fill, versus $7.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 296 30-Day Fills standardized to 30-day supplies 8,785 Days of Medication total across all patients in 2024 | |||
| Atorvastatin Calcium | 97 | $7.27▼ below IN avg | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2024, this provider wrote 97 Medicare prescriptions for Atorvastatin Calcium, about a third of the volume of the typical Indiana prescriber of this medication (236.1). Medicare paid an average of $7.27 per fill, versus $8.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 277.7 30-Day Fills standardized to 30-day supplies 8,330 Days of Medication total across all patients in 2024 | |||
| JardianceEmpagliflozin | 95 | $1,148.01 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 95 Medicare prescriptions for Jardiance, about 1.7 times the volume of the typical Indiana prescriber of this medication (57.5). Medicare paid an average of $1,148.01 per fill, versus $1,017.54 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 190 30-Day Fills standardized to 30-day supplies 5,604 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 75 | $46.86 | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 75 Medicare prescriptions for Levothyroxine Sodium, about half the volume of the typical Indiana prescriber of this medication (178.3). Medicare paid an average of $46.86 per fill, versus $9.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 198.9 30-Day Fills standardized to 30-day supplies 5,920 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl | 64 | $9.17 | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 64 Medicare prescriptions for Metformin Hcl, about 65% of the volume of the typical Indiana prescriber of this medication (98.7). Medicare paid an average of $9.17 per fill, versus $6.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 176 30-Day Fills standardized to 30-day supplies 5,280 Days of Medication total across all patients in 2024 | |||
| Humalog Kwikpen U-100Insulin Lispro | 54 | $491.04 | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 54 Medicare prescriptions for Humalog Kwikpen U-100, about 1.6 times the volume of the typical Indiana prescriber of this medication (33.3). Medicare paid an average of $491.04 per fill, versus $296.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 113.4 30-Day Fills standardized to 30-day supplies 3,277 Days of Medication total across all patients in 2024 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 52 | $128.08 | ▲ More than typical |
In 2024, this provider wrote 52 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 1.7 times the volume of the typical Indiana prescriber of this medication (29.7). Medicare paid an average of $128.08 per fill, versus $93.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 131.6 30-Day Fills standardized to 30-day supplies 3,912 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 50 | $25.29 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 50 Medicare prescriptions for Gabapentin, about half the volume of the typical Indiana prescriber of this medication (110.5). Medicare paid an average of $25.29 per fill, versus $14.41 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 137 30-Day Fills standardized to 30-day supplies 4,110 Days of Medication total across all patients in 2024 | |||
| Glimepiride | 48 | $5.73▼ below IN avg | ≈ Typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. In 2024, this provider wrote 48 Medicare prescriptions for Glimepiride, about the same volume as the typical Indiana prescriber of this medication (50). Medicare paid an average of $5.73 per fill, versus $6.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 116.7 30-Day Fills standardized to 30-day supplies 3,469 Days of Medication total across all patients in 2024 | |||
| TrulicityDulaglutide | 40 | $1,674.43 | ≈ Typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity. In 2024, this provider wrote 40 Medicare prescriptions for Trulicity, about the same volume as the typical Indiana prescriber of this medication (36). Medicare paid an average of $1,674.43 per fill, versus $1,311.97 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 68.8 30-Day Fills standardized to 30-day supplies 2,022 Days of Medication total across all patients in 2024 | |||
| Losartan Potassium | 40 | $9.49 | ▼ Less than typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2024, this provider wrote 40 Medicare prescriptions for Losartan Potassium, about a third of the volume of the typical Indiana prescriber of this medication (118.3). Medicare paid an average of $9.49 per fill, versus $8.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 92 30-Day Fills standardized to 30-day supplies 2,640 Days of Medication total across all patients in 2024 | |||
| FarxigaDapagliflozin Propanediol | 40 | $1,173.32 | ≈ Typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It helps to lower the risk of death from heart disease and reduces the need of going to a doctor or hospital to treat heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 40 Medicare prescriptions for Farxiga, about the same volume as the typical Indiana prescriber of this medication (43). Medicare paid an average of $1,173.32 per fill, versus $915.66 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 82 30-Day Fills standardized to 30-day supplies 2,460 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-100Insulin Degludec | 37 | $628.49▼ below IN avg | ▲ More than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 37 Medicare prescriptions for Tresiba Flextouch U-100, about 1.3 times the volume of the typical Indiana prescriber of this medication (29.1). Medicare paid an average of $628.49 per fill, versus $686.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 81.8 30-Day Fills standardized to 30-day supplies 2,435 Days of Medication total across all patients in 2024 | |||
| SynthroidLevothyroxine Sodium | 35 | $89.95 | ≈ Typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 35 Medicare prescriptions for Synthroid, about the same volume as the typical Indiana prescriber of this medication (37.6). Medicare paid an average of $89.95 per fill, versus $69.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 81.7 30-Day Fills standardized to 30-day supplies 2,450 Days of Medication total across all patients in 2024 | |||
| Insulin Lispro Kwikpen U-100Insulin Lispro | 34 | $428.16 | ≈ Typical |
About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 34 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about the same volume as the typical Indiana prescriber of this medication (29.6). Medicare paid an average of $428.16 per fill, versus $214.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 89.6 30-Day Fills standardized to 30-day supplies 2,593 Days of Medication total across all patients in 2024 | |||
| Pioglitazone Hcl | 32 | $7.77▼ below IN avg | ≈ Typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called "glitazones") used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 32 Medicare prescriptions for Pioglitazone Hcl, about 90% of the volume of the typical Indiana prescriber of this medication (35.6). Medicare paid an average of $7.77 per fill, versus $10.02 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 76 30-Day Fills standardized to 30-day supplies 2,274 Days of Medication total across all patients in 2024 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 32 | $593.92 | ≈ Typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. In 2024, this provider wrote 32 Medicare prescriptions for Basaglar Kwikpen U-100, about the same volume as the typical Indiana prescriber of this medication (32.2). Medicare paid an average of $593.92 per fill, versus $369.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 64.3 30-Day Fills standardized to 30-day supplies 1,900 Days of Medication total across all patients in 2024 | |||
| Rosuvastatin Calcium | 30 | $8.73▼ below IN avg | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2024, this provider wrote 30 Medicare prescriptions for Rosuvastatin Calcium, about a third of the volume of the typical Indiana prescriber of this medication (105.3). Medicare paid an average of $8.73 per fill, versus $10.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 87.6 30-Day Fills standardized to 30-day supplies 2,627 Days of Medication total across all patients in 2024 | |||
| Ezetimibe | 29 | $14.29▼ below IN avg | ▼ Less than typical |
About Ezetimibe: Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Show more ▾ Ezetimibe may be used alone or with other drugs (such as "statins" or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks. An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS. In 2024, this provider wrote 29 Medicare prescriptions for Ezetimibe, about half the volume of the typical Indiana prescriber of this medication (54.2). Medicare paid an average of $14.29 per fill, versus $21.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 54.8 30-Day Fills standardized to 30-day supplies 1,549 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-200Insulin Degludec | 28 | $1,664.93 | ≈ Typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 28 Medicare prescriptions for Tresiba Flextouch U-200, about the same volume as the typical Indiana prescriber of this medication (28.2). Medicare paid an average of $1,664.93 per fill, versus $1,221.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66.2 30-Day Fills standardized to 30-day supplies 1,986 Days of Medication total across all patients in 2024 | |||
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 27 | $1,129.15 | ▼ Less than typical |
In 2024, this provider wrote 27 Medicare prescriptions for Omnipod 5 Dexg7g6 Pods (Gen 5), about 60% of the volume of the typical Indiana prescriber of this medication (44.8). Medicare paid an average of $1,129.15 per fill, versus $1,048.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2024 | |||
| JanuviaSitagliptin Phosphate | 25 | $1,158.68 | ≈ Typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2024, this provider wrote 25 Medicare prescriptions for Januvia, about 76% of the volume of the typical Indiana prescriber of this medication (33). Medicare paid an average of $1,158.68 per fill, versus $977.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.3 30-Day Fills standardized to 30-day supplies 1,600 Days of Medication total across all patients in 2024 | |||
| TradjentaLinagliptin | 23 | $608.53 | ▼ Less than typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2024, this provider wrote 23 Medicare prescriptions for Tradjenta, about half the volume of the typical Indiana prescriber of this medication (38.3). Medicare paid an average of $608.53 per fill, versus $526.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
| Glipizide | 21 | $12.46 | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2024, this provider wrote 21 Medicare prescriptions for Glipizide, about 61% of the volume of the typical Indiana prescriber of this medication (34.2). Medicare paid an average of $12.46 per fill, versus $7.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.8 30-Day Fills standardized to 30-day supplies 1,735 Days of Medication total across all patients in 2024 | |||
| Novolog FlexpenInsulin Aspart | 20 | $606.47 | ▼ Less than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 20 Medicare prescriptions for Novolog Flexpen, about 64% of the volume of the typical Indiana prescriber of this medication (31.4). Medicare paid an average of $606.47 per fill, versus $263.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38.5 30-Day Fills standardized to 30-day supplies 1,156 Days of Medication total across all patients in 2024 | |||
| Lisinopril | 19 | $3.62▼ below IN avg | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2024, this provider wrote 19 Medicare prescriptions for Lisinopril, about 14% of the volume of the typical Indiana prescriber of this medication (132.4). Medicare paid an average of $3.62 per fill, versus $5.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2024 | |||
| RybelsusSemaglutide | 18 | $1,683.26 | ≈ Typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 18 Medicare prescriptions for Rybelsus, about 78% of the volume of the typical Indiana prescriber of this medication (23). Medicare paid an average of $1,683.26 per fill, versus $1,460.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2024 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $1,074.28 | ▼ Less than typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 18 Medicare prescriptions for Toujeo Solostar, about 73% of the volume of the typical Indiana prescriber of this medication (24.7). Medicare paid an average of $1,074.28 per fill, versus $765.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 48.2 30-Day Fills standardized to 30-day supplies 1,433 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 18 | $103.58 | ≈ Typical |
In 2024, this provider wrote 18 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 79% of the volume of the typical Indiana prescriber of this medication (22.7). Medicare paid an average of $103.58 per fill, versus $91.75 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.2 30-Day Fills standardized to 30-day supplies 1,497 Days of Medication total across all patients in 2024 | |||
| Icosapent Ethyl | 15 | $337.31 | ≈ Typical |
About Icosapent Ethyl: Icosapent ethyl is used along with certain other cholesterol medications ("statins" such as atorvastatin, simvastatin) to reduce the risk of heart attack, stroke, and certain types of heart problems that require treatment in a hospital. Show more ▾ It is also used along with a proper diet to help lower fats (triglycerides) in the blood. Icosapent ethyl is a type of omega-3 fatty acid, a fat found in fish oil. It is thought to work by decreasing the amount of triglycerides made by the body. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. In 2024, this provider wrote 15 Medicare prescriptions for Icosapent Ethyl, about 82% of the volume of the typical Indiana prescriber of this medication (18.4). Medicare paid an average of $337.31 per fill, versus $239.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| Humalog Kwikpen U-200Insulin Lispro | 15 | $1,878.13▼ below IN avg | ▼ Less than typical |
About Humalog Kwikpen U-200: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 15 Medicare prescriptions for Humalog Kwikpen U-200, about 69% of the volume of the typical Indiana prescriber of this medication (21.7). Medicare paid an average of $1,878.13 per fill, versus $1,935.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 37.9 30-Day Fills standardized to 30-day supplies 1,138 Days of Medication total across all patients in 2024 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 15 | $84.62 | ▼ Less than typical |
In 2024, this provider wrote 15 Medicare prescriptions for Droplet Pen Needle, about 72% of the volume of the typical Indiana prescriber of this medication (20.9). Medicare paid an average of $84.62 per fill, versus $79.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.1 30-Day Fills standardized to 30-day supplies 998 Days of Medication total across all patients in 2024 | |||
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 14 | $325.61▼ below IN avg | ▼ Less than typical |
About Novolog Mix 70-30 Flexpen: Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2024, this provider wrote 14 Medicare prescriptions for Novolog Mix 70-30 Flexpen, about half the volume of the typical Indiana prescriber of this medication (24.6). Medicare paid an average of $325.61 per fill, versus $348.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 20.1 30-Day Fills standardized to 30-day supplies 489 Days of Medication total across all patients in 2024 | |||
| HumalogInsulin Lispro | 13 | $210.32▼ below IN avg | ▼ Less than typical |
About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 13 Medicare prescriptions for Humalog, about half the volume of the typical Indiana prescriber of this medication (30.2). Medicare paid an average of $210.32 per fill, versus $214.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 17.7 30-Day Fills standardized to 30-day supplies 512 Days of Medication total across all patients in 2024 | |||
| NovologInsulin Aspart | 12 | $531.44 | ▼ Less than typical |
About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 12 Medicare prescriptions for Novolog, about half the volume of the typical Indiana prescriber of this medication (24.7). Medicare paid an average of $531.44 per fill, versus $268.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.2 30-Day Fills standardized to 30-day supplies 997 Days of Medication total across all patients in 2024 | |||
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,180.55 | ▼ Less than typical |
About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 12 Medicare prescriptions for Toujeo Max Solostar, about half the volume of the typical Indiana prescriber of this medication (28.4). Medicare paid an average of $2,180.55 per fill, versus $1,244.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 952 Days of Medication total across all patients in 2024 | |||
| Insulin Lispro | 12 | $93.31 | ▼ Less than typical |
About Insulin Lispro: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 12 Medicare prescriptions for Insulin Lispro, about a third of the volume of the typical Indiana prescriber of this medication (29.8). Medicare paid an average of $93.31 per fill, versus $54.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 478 Days of Medication total across all patients in 2024 | |||
| Novolin R FlexpenInsulin Regular, Human | 11 | $270.86 | ▼ Less than typical |
About Novolin R Flexpen: Insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). Regular insulin preparations that contain the HUMAN insulin peptide sequence. In 2024, this provider wrote 11 Medicare prescriptions for Novolin R Flexpen, about 63% of the volume of the typical Indiana prescriber of this medication (17.5). Medicare paid an average of $270.86 per fill, versus $112.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.6 30-Day Fills standardized to 30-day supplies 456 Days of Medication total across all patients in 2024 | |||
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $1,907.92 | ▼ Less than typical |
About Fiasp Flextouch: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. In 2024, this provider wrote 11 Medicare prescriptions for Fiasp Flextouch, about a third of the volume of the typical Indiana prescriber of this medication (27.5). Medicare paid an average of $1,907.92 per fill, versus $783.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.5 30-Day Fills standardized to 30-day supplies 586 Days of Medication total across all patients in 2024 | |||
| Fluconazole | 11 | $7.57▼ below IN avg | ▼ Less than typical |
About Fluconazole: Fluconazole is used to treat vaginal yeast infections. Show more ▾ It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals. Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. In 2024, this provider wrote 11 Medicare prescriptions for Fluconazole, about half the volume of the typical Indiana prescriber of this medication (23.1). Medicare paid an average of $7.57 per fill, versus $9.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 17 30-Day Fills standardized to 30-day supplies 293 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for AMANDA BRATTON ANP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Shelbyville, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IN prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
